Intrabodies (both single-chain Fv and single-domain VH, VHH, and VL nanobodies) offer
unique solutions to some of the challenges of delivery and target engagement posed by …

The increasing worldwide prevalence of Hepatocellular carcinoma (HCC), characterized by
resistance to conventional chemotherapy, poor prognosis and eventually mortality, place it …

To interfere with cell function, many scientists rely on methods that target DNA or RNA due to
the ease with which they can be applied. Proteins are usually the final executors of function …

Recent studies suggest the enhancement of liver injury in COVID-19 patients infected with
Hepatitis C virus (HCV). Hepatocytes express low levels of angiotensin-converting enzyme 2 …

Hepatocellular carcinoma (HCC) represents the fifth most common cancer worldwide and
the third cause of cancer-related mortality. Hepatitis C virus (HCV) is the leading cause of …

The rapid and ongoing discovery of new disease related biomarkers leads to a dramatic
paradigm change in human healthcare and constitutes the basis for a truly personalized …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and has become a
global health threat. No HCV vaccine is currently available and treatment with antiviral …

Four major components of epigenetic regulation are promoter methylation, histone
modification, chromatin conformation changes, and altered expression of noncoding RNAs …

Abstract Purpose of Review Heart failure is a syndrome with poor prognosis and no curative
options for the majority of patients. The standard one-size-fits-all-treatment approach …

Hepatitis C virus (HCV) infection is the leading cause of chronic hepatitis, which often results
in liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC). HCV possesses an RNA …